Cameco Trades at 65x 2026 Earnings After 80% Rally on Nuclear Expansion

CCJCCJ

Cameco shares have surged nearly 80% over the past year and trade at roughly 65x projected 2026 earnings, reflecting its $44 billion market cap. The uranium miner stands to benefit from commitments by multiple countries to triple nuclear capacity by 2050 and U.S. incentives for small modular reactor development.

1. Stock Performance and Valuation Metrics

Cameco Corporation (CCJ) has seen its share price rally nearly 80% over the past year, driven by a surge in investor interest in nuclear power. The company’s market capitalization stands at approximately $44 billion, with an average daily trading volume of 4.7 million shares. At recent levels, the stock trades at roughly 65 times its projected 2026 earnings of $1.52 per share (non-GAAP), reflecting elevated expectations that have stretched valuation multiples compared with the broader energy sector. Cameco’s current dividend yield is 0.17%, and its gross margin sits at 26.65%.

2. Nuclear Expansion as a Long-Term Growth Driver

Cameco benefits from commitments by multiple countries to triple nuclear capacity by 2050, as governments seek reliable, zero-carbon baseload power to complement intermittent renewables. The U.S. government is expediting regulatory approvals for new reactor construction, and emerging technologies—such as small modular reactors (SMRs) and microreactors—offer potential new revenue streams. Cameco’s supply agreements with utilities in North America and Europe position it to capture incremental volume growth, supported by uranium price forecasts of around $105 per pound next year according to major commodity analysts.

3. Analyst Recommendations and Outlook

Bank of America has named Cameco as one of its top three mining picks for 2026, highlighting the company’s exposure to a commodity that could see spot uranium prices rise by more than 40% year-over-year. Of the 20 analysts covering CCJ, the consensus EPS estimate for 2026 is $1.52, with several firms rating the stock as ‘Buy’ based on expected tightening in the uranium market. However, the elevated forward P/E multiple suggests that any shortfall in production growth or delays in reactor build-outs could lead to heightened share-price volatility.

Sources

FBZP